logo

Roy Herbst, MD

Roy Herbst, MD, PhD

Oncology New Haven, CT

Ensign Professor of Medicine and Professor of Pharmacology; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven; Associate Director for Translational Research, Yale Cancer Center; Clinical Research Program Leader, Thoracic Oncology Program, Yale Cancer Center

Office Address

Office Map
  • Smilow Cancer Hospital at Yale
    South Frontage Road & Park Street, 4th Floor Multispecialty Care Center
    New Haven, CT 06510
    Phone: (203) 785-6879
    Fax: (203) 737-5698

Summary

  • Dr. Roy Herbst, MD is a board certified oncologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut. He is affiliated with Yale-New Haven Hospital.

Dr. Herbst's Clinical Specialties & Interests

  • Oncology: Thoracic Cancer

Dr. Herbst's Education & Medical Training

  • Brigham and Women's HospitalBrigham and Women's HospitalFellowship, Medical Oncology
  • Brigham and Women's HospitalBrigham and Women's HospitalResidency, Internal Medicine
  • Cornell Univ Med CollWeill Cornell Medical College of Cornell UniversityMedical School

Dr. Herbst's Certifications & Licensure

  • CT State Medical LicenseCT State Medical License2011 - 2015
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Herbst's Awards, Honors, & Recognition

  • SuperDoctors.comSuper DoctorSuperDoctors.com

Dr. Herbst's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Personalizing Nsclc Therapy: Exploiting KRAS Activated Pathways
    Personalizing Nsclc Therapy: Exploiting KRAS Activated PathwaysNational Cancer Institute
    2011 - 2011
  • U10 Full Member Application Affiliated With SWOG
    U10 Full Member Application Affiliated With SWOGNational Cancer Institute
    2010 - 2010
  • U10 Ful Member Application Affiliated With SWOG
    U10 Ful Member Application Affiliated With SWOGNational Cancer Institute
    2009 - 2009
  • Phase I Trial Of Antiangiogenic Agent SU6668 In PT W Solid Tumors
    Phase I Trial Of Antiangiogenic Agent SU6668 In PT W Solid TumorsNational Cancer Institute
    2001 - 2002
  • Core--Clinical Trials
    Core--Clinical TrialsNational Cancer Institute
    2001 - 2002

Insurance Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Connecticare FlexPOS
  • GHI PPO
  • Great West PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Alternate Names

  • Dr. Roy Herbst, Dr. Roy Herbst, MD, Dr. R Herbst, Dr. Roy S. Herbst

39 Colleague Invites!
Is this you? If so, register to see 39 messages.

Physicians, view Dr. Herbst's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV